Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | September 11, 2025 01:06pm

Gainers

  • Profusa (NASDAQ:PFSA) stock rose 74.3% to $0.46 during Thursday's regular session. The market value of their outstanding shares is at $8.9 million.
  • Maze Therapeutics (NASDAQ:MAZE) shares increased by 49.25% to $23.91. The company's market cap stands at $702.4 million.
  • Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares increased by 37.36% to $0.04.
  • GRI Bio (NASDAQ:GRI) stock increased by 35.89% to $2.12. The market value of their outstanding shares is at $3.9 million.
  • ProKidney (NASDAQ:PROK) stock moved upwards by 32.4% to $2.86. The market value of their outstanding shares is at $291.5 million.
  • PACS Group (NYSE:PACS) stock increased by 28.85% to $9.94. The company's market cap stands at $1.1 billion.

Losers

  • EUDA Health Holdings (NASDAQ:EUDA) stock declined by 20.1% to $1.11 during Thursday's regular session. The market value of their outstanding shares is at $51.6 million.
  • Revelation Biosciences (NASDAQ:REVB) shares decreased by 18.83% to $2.0. The company's market cap stands at $4.1 million.
  • Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock decreased by 17.91% to $1.33. The market value of their outstanding shares is at $11.9 million.
  • Exicure (NASDAQ:XCUR) shares decreased by 14.6% to $3.19. The market value of their outstanding shares is at $23.5 million.
  • Kindly MD (NASDAQ:NAKA) shares fell 14.54% to $4.1. The market value of their outstanding shares is at $1.8 billion.
  • MSP Recovery (NASDAQ:MSPR) shares fell 14.45% to $1.66. The company's market cap stands at $1.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CELGR CUPR EUDA GRI MAZE MSPR NAKA PACS PFSA PROK REVB XCUR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist